BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38312062)

  • 1. Effects of postoperative antioxidants on the salivary glands in patients with thyroid cancer undergoing radioactive iodine-131 treatment.
    Tong H; Yue R; Fang J; Li X; Yang S; Hou Y; Wang R; Zhang B; Liu H; Wu Z; Cheng Y
    Nucl Med Commun; 2024 Apr; 45(4):312-320. PubMed ID: 38312062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial.
    Upadhyaya A; Zhou P; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z; Wang X; Zhang X; Zhang W
    Nucl Med Commun; 2017 Nov; 38(11):891-903. PubMed ID: 28806348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin E and supragingival scaling on salivary gland function in patients with differentiated thyroid cancer treated with 131I.
    Cheng Y; Tong H; Li X; Zhang X; Fang J; Yue R; Huang N; Tian J; Yu F; Gao Y
    Nucl Med Commun; 2022 Sep; 43(9):995-1003. PubMed ID: 35950355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer.
    Son H; Lee SM; Yoon RG; Lee H; Lee I; Kim S; Chung WY; Lee JW
    Hell J Nucl Med; 2017; 20(1):62-70. PubMed ID: 28315910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?
    Fallahi B; Beiki D; Abedi SM; Saghari M; Fard-Esfahani A; Akhzari F; Mokarami B; Eftekhari M
    Nucl Med Commun; 2013 Aug; 34(8):777-86. PubMed ID: 23708871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: A systematic review of randomized controlled trials.
    Auttara-Atthakorn A; Sungmala J; Anothaisintawee T; Reutrakul S; Sriphrapradang C
    Front Endocrinol (Lausanne); 2022; 13():960265. PubMed ID: 36105397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer.
    Upadhyaya A; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Zhou P; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z
    Medicine (Baltimore); 2017 Jun; 96(25):e7164. PubMed ID: 28640094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
    Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
    Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.
    Liu B; Huang R; Kuang A; Zhao Z; Zeng Y; Wang J; Tian R
    Med Phys; 2011 Oct; 38(10):5412-9. PubMed ID: 21992360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiated thyroid cancer and selenium supplements for protection of salivary glands from
    Mazokopakis E
    Hell J Nucl Med; 2018; 21(1):83-84. PubMed ID: 29550852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Scintigraphy Evaluated the Relationship between 131I Therapy and Salivary Glands Function in DTC Patients: A Retrospective Analysis.
    Lv X; Yin L; Wu W; Li N; Zhang R; Li X; Jia Q; Tan J; Wang P; Zheng X; He X; Huang C; Li D; Wang Y; Meng Z
    J Healthc Eng; 2022; 2022():7640405. PubMed ID: 35463665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer.
    Nomura K; Nakayama M; Okizaki A
    Ann Nucl Med; 2023 Aug; 37(8):462-469. PubMed ID: 37149836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary gland function in thyroid cancer patients with radioiodine administration history.
    Krcalova E; Horacek J; Gabalec F; Zak P; Dolezal J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):277-283. PubMed ID: 31223135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.
    Nabaa B; Takahashi K; Sasaki T; Okizaki A; Aburano T
    AJNR Am J Neuroradiol; 2012 Nov; 33(10):1964-70. PubMed ID: 22555571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Controlled Trial for the Effectiveness of Aromatherapy in Decreasing Salivary Gland Damage following Radioactive Iodine Therapy for Differentiated Thyroid Cancer.
    Nakayama M; Okizaki A; Takahashi K
    Biomed Res Int; 2016; 2016():9509810. PubMed ID: 28042578
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of sodium/iodide symporter expression in the salivary gland.
    La Perle KM; Kim DC; Hall NC; Bobbey A; Shen DH; Nagy RS; Wakely PE; Lehman A; Jarjoura D; Jhiang SM
    Thyroid; 2013 Aug; 23(8):1029-36. PubMed ID: 23441638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial.
    Liu B; Kuang A; Huang R; Zhao Z; Zeng Y; Wang J; Tian R
    J Nucl Med; 2010 Apr; 51(4):618-23. PubMed ID: 20237029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer.
    Lee SM; Lee JW; Kim SY; Han SW; Bae WK
    Ann Nucl Med; 2013 Oct; 27(8):700-9. PubMed ID: 23921836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
    Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
    Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of Parotid and Submandibular Glands With Shear Wave Elastography Following Radioactive Iodine Therapy for Papillary Thyroid Carcinoma.
    Rahatli FK; Turnaoglu H; Iyidir OT; Kirnap NG; Haberal KM; Aydın E; Uslu N
    J Ultrasound Med; 2019 Feb; 38(2):357-362. PubMed ID: 30027680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.